These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 31055730)

  • 1. Association of homocysteine, folate, and white matter hyperintensities in Parkinson's patients with different motor phenotypes.
    Shen Y; Dong ZF; Pan PL; Xu G; Huang JY; Liu CF
    Neurol Sci; 2019 Sep; 40(9):1855-1863. PubMed ID: 31055730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. White matter hyperintensities in Parkinson's disease: do they explain the disparity between the postural instability gait difficulty and tremor dominant subtypes?
    Herman T; Rosenberg-Katz K; Jacob Y; Auriel E; Gurevich T; Giladi N; Hausdorff JM
    PLoS One; 2013; 8(1):e55193. PubMed ID: 23383104
    [TBL] [Abstract][Full Text] [Related]  

  • 3. White matter hyperintensities and the progression from mild parkinsonian signs to parkinsonism and Parkinson's disease.
    Huo Y; Hong W; Huang J; Wang C; Ma J; Liu D; Chen L; Peng Z; Dong S; Tao Y; Li L; Liu L; Yang H; Zhou H
    Neurobiol Aging; 2020 Dec; 96():267-276. PubMed ID: 33130544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploring the association between Cerebral small-vessel diseases and motor symptoms in Parkinson's disease.
    Wan Y; Hu W; Gan J; Song L; Wu N; Chen Y; Liu Z
    Brain Behav; 2019 Apr; 9(4):e01219. PubMed ID: 30815987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of MRI white matter hyperintensities on dementia in Parkinson's disease in relation to the homocysteine level and other vascular risk factors.
    Sławek J; Roszmann A; Robowski P; Dubaniewicz M; Sitek EJ; Honczarenko K; Gorzkowska A; Budrewicz S; Mak M; Gołąb-Janowska M; Koziorowska-Gawron E; Droździk M; Kurzawski M; Bandurski T; Białecka M
    Neurodegener Dis; 2013; 12(1):1-12. PubMed ID: 22831964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between white matter lesions and Parkinson's disease: an impact on Postural/Gait difficulty phenotype and cognitive performance.
    Sinani O; Dadouli K; Ntellas P; Kapsalaki EZ; Vlychou M; Raptis DG; Marogianni C; Markou K; Dardiotis E; Xiromerisiou G
    Neurol Res; 2022 Dec; 44(12):1122-1131. PubMed ID: 35994524
    [TBL] [Abstract][Full Text] [Related]  

  • 7. White matter changes and the development of motor phenotypes in de novo Parkinson's Disease.
    Moccia M; Tedeschi E; Ugga L; Erro R; Picillo M; Caranci F; Barone P; Brunetti A
    J Neurol Sci; 2016 Aug; 367():215-9. PubMed ID: 27423590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of COMT, MTHFR, and SLC19A1(RFC-1) polymorphisms with homocysteine blood levels and cognitive impairment in Parkinson's disease.
    Białecka M; Kurzawski M; Roszmann A; Robowski P; Sitek EJ; Honczarenko K; Gorzkowska A; Budrewicz S; Mak M; Jarosz M; Gołąb-Janowska M; Koziorowska-Gawron E; Droździk M; Sławek J
    Pharmacogenet Genomics; 2012 Oct; 22(10):716-24. PubMed ID: 22890010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. White matter hyperintensities as a predictor of freezing of gait in Parkinson's disease.
    Chung SJ; Lee YH; Yoo HS; Oh JS; Kim JS; Ye BS; Sohn YH; Lee PH
    Parkinsonism Relat Disord; 2019 Sep; 66():105-109. PubMed ID: 31324555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. White matter hyperintensity burden predicts cognitive but not motor decline in Parkinson's disease: results from the Ontario Neurodegenerative Diseases Research Initiative.
    Carvalho de Abreu DC; Pieruccini-Faria F; Sarquis-Adamson Y; Black A; Fraser J; Van Ooteghem K; Cornish B; Grimes D; Jog M; Masellis M; Steeves T; Nanayakkara N; Ramirez J; Scott C; Holmes M; Ozzoude M; Berezuk C; Symons S; Mohammad Hassan Haddad S; Arnott SR; Binns M; Strother S; Beaton D; Sunderland K; Theyers A; Tan B; Zamyadi M; Levine B; Orange JB; Roberts AC; Lou W; Sujanthan S; Breen DP; Marras C; Kwan D; Adamo S; Peltsch A; Troyer AK; Black SE; McLaughlin PM; Lang AE; McIlroy W; Bartha R; ; Montero-Odasso M
    Eur J Neurol; 2023 Apr; 30(4):920-933. PubMed ID: 36692250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microstructural Connectivity is More Related to Cognition than Conventional MRI in Parkinson's Disease.
    Lee YH; Lee WJ; Chung SJ; Yoo HS; Jung JH; Baik K; Sohn YH; Seong JK; Lee PH
    J Parkinsons Dis; 2021; 11(1):239-249. PubMed ID: 33074193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sexual dysfunction is associated with postural instability gait difficulty subtype of Parkinson's disease.
    Deng X; Xiao B; Li HH; Lo YL; Chew LM; Prakash KM; Tan EK
    J Neurol; 2015 Nov; 262(11):2433-9. PubMed ID: 26210749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The burden of white matter hyperintensities is a predictor of progressive mild cognitive impairment in patients with Parkinson's disease.
    Sunwoo MK; Jeon S; Ham JH; Hong JY; Lee JE; Lee JM; Sohn YH; Lee PH
    Eur J Neurol; 2014 Jun; 21(6):922-e50. PubMed ID: 24661277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Executive function network's white matter alterations relate to Parkinson's disease motor phenotype.
    Yang Q; Nanivadekar S; Taylor PA; Dou Z; Lungu CI; Horovitz SG
    Neurosci Lett; 2021 Jan; 741():135486. PubMed ID: 33161103
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topography of cortical thinning associated with white matter hyperintensities in Parkinson's disease.
    Ham JH; Yun HJ; Sunwoo MK; Hong JY; Lee JM; Sohn YH; Lee PH
    Parkinsonism Relat Disord; 2015 Apr; 21(4):372-7. PubMed ID: 25697488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cross-sectional and longitudinal associations between total and regional white matter hyperintensity volume and cognitive and motor function in Parkinson's disease.
    Pozorski V; Oh JM; Okonkwo O; Krislov S; Barzgari A; Theisen F; Sojkova J; Bendlin BB; Johnson SC; Gallagher CL
    Neuroimage Clin; 2019; 23():101870. PubMed ID: 31150958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential White Matter Regional Alterations in Motor Subtypes of Early Drug-Naive Parkinson's Disease Patients.
    Wen MC; Heng HSE; Lu Z; Xu Z; Chan LL; Tan EK; Tan LCS
    Neurorehabil Neural Repair; 2018 Feb; 32(2):129-141. PubMed ID: 29347868
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mild cognitive impairment in patients with Parkinson´s disease and the analysis of associated factors.
    Kobak Tur E; Ari BC
    Neurol Res; 2023 Dec; 45(12):1161-1168. PubMed ID: 37743634
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Postural and gait symptoms in de novo Parkinson's disease patients correlate with cholinergic white matter pathology.
    Nazmuddin M; van Dalen JW; Borra RJH; Stormezand GN; van der Horn HJ; van der Zee S; Boertien J; van Laar T
    Parkinsonism Relat Disord; 2021 Dec; 93():43-49. PubMed ID: 34784526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. White Matter Hyperintensities and Mild Cognitive Impairment in Parkinson's Disease.
    Mak E; Dwyer MG; Ramasamy DP; Au WL; Tan LC; Zivadinov R; Kandiah N
    J Neuroimaging; 2015; 25(5):754-60. PubMed ID: 25753576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.